Skip to main content
. Author manuscript; available in PMC: 2020 Jan 15.
Published in final edited form as: J Neuromuscul Dis. 2019;6(3):271–287. doi: 10.3233/JND-190389

Fig. 3.

Fig. 3.

A summary of the work-flow used by Kawahara et al. [77] to screen for novel drug candidates. Similar work-flows have been used by others to identify potential therapeutics for DMD and LGMD2I [99, 120]. See text for details.